tiprankstipranks
Trending News
More News >
Doximity (DOCS)
NYSE:DOCS
US Market

Doximity (DOCS) Earnings Dates, Call Summary & Reports

Compare
820 Followers

Earnings Data

Report Date
Aug 12, 2025
TBA Not Confirmed
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.3
Last Year’s EPS
0.28
Same Quarter Last Year
Moderate Buy
Based on 16 Analysts Ratings

Earnings Call Summary

Earnings Call Date:May 15, 2025
|
% Change Since: -6.64%
|
Next Earnings Date:Aug 12, 2025
Earnings Call Sentiment|Positive
Doximity demonstrated strong financial performance and user engagement, driven by revenue growth, robust EBITDA margins, and successful adoption of AI tools. Despite the strong results, the company remains cautious about potential macroeconomic challenges and tougher year-over-year comparisons.
Company Guidance
During Doximity's Q4 2025 earnings call, the company reported robust financial performance with a revenue of $138 million for the quarter, surpassing the high-end of their guidance by 4%, and a total annual revenue of $570 million, marking a 20% year-on-year increase. The top 20 clients grew by 23% while adjusted EBITDA margin stood at 50% for the quarter and 55% for the year, with free cash flow reaching $97 million, a 56% increase from the previous year. Doximity's network growth was driven by record highs in unique active users across all metrics, particularly for their newsfeed and AI tools, which grew fivefold year-on-year. The company hosted successful physician and pharma client summits, highlighting the adoption of their AI tools like Doximity GPT. For fiscal 2026, they anticipate revenue of $619-$631 million, reflecting a 10% growth, and an adjusted EBITDA of $333-$345 million, with a 54% margin, while 70% of subscription-based revenue is under contract. Doximity continues to invest in AI, aiming for long-term efficiency and growth, despite the macroeconomic uncertainties.
Revenue Growth Exceeds Expectations
Doximity reported $138 million in revenue for the fourth quarter, 4% above the high-end of the guidance range. For the full fiscal year, revenue was $570 million, representing a 20% year-on-year growth.
Strong EBITDA Performance
Adjusted EBITDA margin for the fourth quarter was 50%, translating to $70 million, which was 10% above the high-end of the guidance.
Record User Engagement
Unique active users across all timeframes hit fresh highs in Q4. Newsfeed user engagement saw record highs with articles read or tapped up more than 30% year-on-year.
AI Tools Rapid Growth
AI tools usage grew more than 5x year-on-year, indicating strong adoption and integration into medical workflows.
Successful Client Summits
Positive feedback from the 13th Annual Physician Tech Summit and the Annual Pharma Client Summit, with strong interest in AI-powered solutions.
Robust Free Cash Flow
Free cash flow for the fourth quarter was $97 million, up 56% year-on-year. For the full fiscal year, free cash flow was $267 million, an increase of 50% year-on-year.

Doximity (DOCS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DOCS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 12, 2025
2026 (Q1)
0.30 / -
0.28
May 15, 2025
2025 (Q4)
0.27 / 0.38
0.2552.00% (+0.13)
Feb 06, 2025
2025 (Q3)
0.34 / 0.45
0.2955.17% (+0.16)
Nov 07, 2024
2025 (Q2)
0.26 / 0.30
0.2236.36% (+0.08)
Aug 08, 2024
2025 (Q1)
0.22 / 0.28
0.1947.37% (+0.09)
May 16, 2024
2024 (Q4)
0.20 / 0.25
0.225.00% (+0.05)
Feb 08, 2024
2024 (Q3)
0.24 / 0.29
0.2231.82% (+0.07)
Nov 09, 2023
2024 (Q2)
0.17 / 0.22
0.1729.41% (+0.05)
Aug 08, 2023
2024 (Q1)
0.14 / 0.19
0.1435.71% (+0.05)
May 16, 2023
2023 (Q4)
0.17 / 0.20
0.21-4.76% (>-0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DOCS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 15, 2025
$58.45$52.56-10.08%
Feb 06, 2025
$58.26$79.23+35.99%
Nov 07, 2024
$43.42$58.25+34.15%
Aug 08, 2024
$25.66$35.60+38.74%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Doximity (DOCS) report earnings?
Doximity (DOCS) is schdueled to report earning on Aug 12, 2025, TBA Not Confirmed.
    What is Doximity (DOCS) earnings time?
    Doximity (DOCS) earnings time is at Aug 12, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is DOCS EPS forecast?
          DOCS EPS forecast for the fiscal quarter 2026 (Q1) is 0.3.

            Doximity (DOCS) Earnings News

            DOCS Earnings: Doximity Stock Gains on Impressive Q4 Report
            Premium
            Market News
            DOCS Earnings: Doximity Stock Gains on Impressive Q4 Report
            1y ago
            Doximity (NYSE:DOCS) Surges after Q2 Results Beat Estimates
            Premium
            Market News
            Doximity (NYSE:DOCS) Surges after Q2 Results Beat Estimates
            2y ago
            Doximity (NYSE: DOCS) Crashes after Lowered Guidance
            Premium
            Market News
            Doximity (NYSE: DOCS) Crashes after Lowered Guidance
            2y ago
            Doximity Dives despite Winning Earnings Report
            Premium
            Market News
            Doximity Dives despite Winning Earnings Report
            2y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis